KANSAS OFFICIALS ADDRESS UNPRECEDENTED TUBERCULOSIS OUTBREAK IN WYANDOTTE COUNTY
Kansas health officials are addressing an “unprecedented” tuberculosis (TB) outbreak in Wyandotte County. During a Senate committee meeting on January 21, 2025, Ashley Goss, the Kansas Department of Health and Environment’s deputy secretary for Public Health, reported that the number of active TB cases decreased in 2024. However, 60 active cases remain in Wyandotte County, with an additional seven cases in neighboring Johnson County. The Kansas Department of Health and Environment (KDHE) continues to collaborate with the Centers for Disease Control and Prevention (CDC) and local health authorities to track and treat the outbreak. Goss highlighted the agency’s 2025 goal to engage with large employers in the county to identify further cases. Tuberculosis primarily affects the lungs but can have other impacts, with some patients experiencing latent TB, which is not contagious. (KSHB)
H5N1 BIRD FLU SPREADS TO CATTLE AND HUMANS EXPERTS ALARMED
The H5N1 bird flu outbreak, which first affected dairy cattle a year ago, has since spread to over 900 herds and dozens of people, causing increasing concern among experts. While a human pandemic isn’t inevitable, the virus shows signs of potential evolution, as evidenced by reinfections in Idaho’s dairy herds. Experts fear that the virus could become endemic in cattle, obscuring detection and allowing for mutations that might facilitate human transmission. Though there are federal precautions in place, including a vaccine stockpile, delays in testing, inadequate data release, and slow responses from the Department of Agriculture have hindered containment efforts. Infections in mammals, including cats and farmworkers, have raised alarms. The virus’s spread through food sources like raw milk and pet food is particularly worrisome. Experts stress that improved surveillance and education for farmworkers are critical to controlling the outbreak, as the situation continues to evolve. (New York Times)
EAST ASIAN AMERICANS UNDERREPRESENTED IN LEADERSHIP ROLES IN BIOTECH
A report from ElevAAte Biotech highlights a significant disparity in leadership representation for East Asian Americans in the U.S. biopharma sector. Despite comprising a large portion of entry-level employees at top biopharma companies, East Asian Americans hold only 7% of C-suite roles across companies valued at $500 million or more, with just 2.75% in Big Pharma. The report also found that 54% of East Asian American CEOs ascended through founding their own companies, compared to 27% of white CEOs. While Asian Americans make up a quarter of entry-level employees, they constitute only 11% of C-suite executives, and no East Asian American has ever been CEO of a U.S.-based Big Pharma. ElevAAte Biotech, a nonprofit founded to address this gap, provides networking opportunities, leadership training, and highlights role models. The organization is initially focused on East Asian Americans in biopharma but plans to expand its efforts to other life sciences and Asian American communities. (Fierce Biotech)
LAWMAKERS PUSH RELIGIOUS EXEMPTIONS AND VACCINE REGULATIONS ACROSS STATES
In over 15 states, lawmakers are introducing bills to either revive or create new religious exemptions from vaccination mandates, establish state-level vaccine injury databases, or regulate what providers must disclose to patients about vaccines. Many of these efforts are fueled by political shifts, including President Trump’s return and Robert F. Kennedy Jr.’s nomination as Secretary of Health and Human Services. Amid declining childhood vaccination rates and increasing vaccine exemptions, the U.S. saw a rise in whooping cough and measles outbreaks in 2024. Some states, like West Virginia, are adding religious exemptions, while others, like Connecticut, are revisiting past exemptions. Meanwhile, Hawaii is considering eliminating non-medical waivers. Other bills focus on parental consent, vaccine ingredients, and vaccine injury reporting. Experts argue that these efforts could hinder vaccination efforts and suggest focusing on removing barriers to vaccination rather than creating new ones, noting that vaccines have been vital in preventing serious infections. (AP)
DEEPSEEK CHATBOT RAISES QUESTIONS ABOUT FUTURE OF US AI INDUSTRY
The emergence of DeepSeek, a Chinese chatbot startup, has raised concerns over the future of the U.S. artificial intelligence (AI) boom. DeepSeek’s AI assistant surpassed OpenAI’s ChatGPT in popularity in the U.S. and UK, and its advanced model was developed using less powerful, cheaper chips compared to rivals. This has led to doubts about the sustainability of the multibillion-dollar AI investments made by U.S. companies like Nvidia, Microsoft, and Meta. DeepSeek’s R1 model, developed with H800 chips and a budget of under $6 million, reportedly outperforms OpenAI’s models and others from Google, Meta, and Anthropic. The company’s success without access to the latest U.S. technology raises questions about the effectiveness of U.S. sanctions on China’s tech sector. The development has caused a significant drop in global technology shares, with U.S. chipmaker Nvidia seeing major losses, and investors are now questioning the future of AI infrastructure investments. (The Guardian)
ANTHROPIC INTRODUCES CITATIONS FEATURE TO IMPROVE CLAUDE MODELS’ ACCURACY
Anthropic has introduced a new feature called Citations for its Claude models, which helps prevent confabulations (or hallucinations) by linking responses to specific source documents. The Citations API allows developers to add documents to Claude’s context window, enabling it to automatically cite relevant passages when answering questions. The feature works by chunking documents into sentences and passing these along with user queries to the model. It has shown a 15% improvement in recall accuracy during internal testing, offering potential uses in summarizing case files, answering questions from financial documents, and supporting systems with cited product documentation. Early adopters like Thomson Reuters and Endex have reported promising results, with Endex seeing a reduction in source confabulations from 10% to zero. However, some experts caution that while Citations is a step forward, relying on any LLM for accurate referencing still carries risks. (Ars Technica)
TRUMP ADMINISTRATION IMPOSES RESTRICTIONS ON NIH OPERATIONS AND PROGRAMS
The Trump administration’s ongoing restrictions on the National Institutes of Health (NIH) have included a communications pause, a halt on peer reviews and meetings until February, and a freeze on purchases and service visits for equipment, which raises concerns about running out of supplies and animal feed. NIH staff have also been prohibited from sending reviews or commentaries to journals, though they can still submit research papers. The NIH’s diversity, equity, and inclusion programs have been dismantled, and Matthew Memoli, an influenza researcher at the National Institute of Allergy and Infectious Diseases (NIAID), has been appointed acting director. Memoli, who has limited management experience, was recommended by Jay Bhattacharya, Trump’s nominee for the permanent role. Meanwhile, former NIH chief Dr. Anthony Fauci, who retired in 2022, will now pay for his own security detail, a cost previously covered by the government after he received death threats during the pandemic. (Science)
STUDY SHOWS RSV VACCINE EFFECTIVE IN OLDER VETERANS DESPITE LOW UPTAKE
A study published in The Lancet Infectious Diseases estimated the effectiveness of the RSV vaccine in older U.S. veterans during the 2023-2024 season. The study found that a single dose of the vaccine had an effectiveness of 78% against RSV infection, 79% against emergency department visits, and 80% against hospitalization. The study used electronic health records from the Veterans Health Administration to compare vaccinated veterans aged 60 and older with unvaccinated controls. Despite the positive findings, only 24% of eligible adults in the U.S. received the RSV vaccine by the end of the season. The study also highlighted the vaccine’s effectiveness in high-risk groups, such as those with weakened immune systems and older veterans. However, experts caution that more research is needed to assess the long-term effectiveness, optimal vaccination schedules, and the impact on post-RSV ICU admissions and deaths. (CIDRAP)
ECOLOGIST THOMAS CROWTHER LEAVES ETH ZURICH AMID MISCONDUCT ALLEGATIONS
Thomas Crowther, a prominent ecologist known for his influential research on trees, will leave ETH Zurich after the institution decided not to renew his contract. ETH Zurich cited “reports of alleged misconduct on a variety of levels” and a loss of trust in Crowther. The allegations have not been detailed, and both Crowther and the university declined to comment. Crowther’s lab, which employs 40–60 people, will be dissolved, and staff were informed they would lose their jobs by September. Crowther gained prominence for his 2015 Nature paper estimating nearly eight times more trees on Earth than previously thought, which influenced global conservation initiatives. In 2017, he secured substantial funding for a long-term project at ETH Zurich. However, his career has been marked by controversy, including criticism of a 2019 paper that overestimated the carbon sequestration potential of tree planting. Crowther is considering offers to relocate his lab to another institution in Europe or Asia. (Nature)
CHINESE NEW YEAR TRAVEL RUSH DRIVES ECONOMIC ACTIVITY AND CONSUMER CONFIDENCE
Millions of people across China are traveling back to their hometowns for the Chinese New Year, marking the peak of the 40-day Spring Festival travel rush, or Chunyun. This year’s travel period, expected to peak just before Chinese New Year Eve, involves the largest human migration in the world, with Shanghai’s Hongqiao Railway Station seeing a doubling of passengers at its busiest point. With over 9 billion domestic trips projected, Chunyun is a key driver of economic activity, boosting consumption in gifts, food, transport, and entertainment. Despite China’s economic challenges, this spending surge reflects consumer confidence. While rail remains a major transport mode, car travel has surged, with 7.2 billion road trips expected this year, thanks to a rise in car ownership. The travel rush highlights broader trends, such as urbanization and changing consumer habits, as more people move to cities like Shanghai for work, with many returning to rural areas for the traditional holiday reunion. (Channel News Asia)
Thanks for reading. Let’s be careful out there.
WORDS: The Biology Guy.
IMAGE CREDIT: NIAID.
Leave a Reply